The mortality charts based on annual information about the survival rates from prostate cancer indicate a large number of deaths caused by this type of cancer, although the newer methods of detection prove to be more efficient in establishing a correct diagnose.

That doesn’t necessarily mean that the screening tests are inefficient. In fact, the screening tests only indicate an abnormality with the prostate organ; the digital rectal exam done by inserting a gloved finger into the rectum to palpate the size of the prostate can easily indicate any whether a lump or a hardness is felt on the surface on it. The prostate specific antigen blood tests indicate the levels of the prostate specific antigen protein, which should be low in normal conditions. The results of the screening tests have to be interpreted by medical specialists who will eventually decide if the medical investigation should continue or not.

In most of the cases the prostate cancer isn’t noticeable in its first stages since it has so early signs or symptoms. When the primary malignant tumor starts its spreading to other regions of the body and the cancer cells have entered the bloodstream or the lymph system and travel to vital organs such as the lungs and brain, where they will allow the developing of other small and secondary tumors until the cancer becomes metastatic, the patient will report some unusual symptoms.



As old as it may be, the screening test still remains the best method of detecting the cancer in its early stages.

For an accurate result, the prostate biopsy is complemented by some newer methods of detection such as the prostate mapping or the nomogram.

Based on the charts of prostate cancer mortality the prognosis for the outcome is not so optimistic, rather it is well know the fact that every year, around the world, one in six men gets to be diagnosed with a prostate cancer and only the lung cancer causes more deaths than the prostate cancer.

Cancer is seen as an abnormal condition having as main causes some factors such as the working environment and the alimentation, the smoking or excessive alcohol drinking, the ageing process, the genetic inheritance since cancer can be inherited via the members of a family and even race. These factors allow the fast development or multiplication of the cancer cells while the normal ones experience a rapid death because of the malfunctioning of the apoptotic reaction and the mitosis.

The prognosis gets challenging because each cancer is unique and that means that the same type of cancer can develop in different people at different stages, in different periods of time with different effects on the general health of that certain patient.



The mortality statistic charts help the medical specialists determine some of the prostate cancer characteristics such as its progression or evolution in different people in different regions of the world and search for treatment alternatives.

Usually the prognosis has two results: either the patient will respond well to the prescribed treatment, no matter what the stage of his cancer is, or the treatment will prove inefficient to stop or even delay the progression of the prostate cancer.

In America as well as in some parts of Europe like Great Britain, the survival rate of five year after the initial diagnose if of about ninety eight percent while the one for ten year survival rate is of ninety one percent. The chances or survival increase if the cancer is detected in its early stages and after the fifteen survival trial the results tend to stabilize and there is even the chance of curing the cancer. Usually, the cancer recurrence happens in the next five years after the initial treatment; after this period of time the chances of recurrence drop.

The fifteen year survival rate is of about seventy six percent but if the cancer becomes locally advance or metastatic, life can be prolonged only with the help of some strong and effective treatment such as the hormone therapy or radiotherapy.

The lifetime probability of developing a prostate cancer is about sixteen percent and the results indicated by the mortality charts can only increase the angst and the depressive moods of a patient if they are revealed.

For example, in America, by the beginning of the year 2009, it was estimated that almost two thousand cases of prostate cancer will be diagnosed while almost thirty thousand patients will die because of it. The positive news is that almost two million Americans diagnosed with prostate cancer are still alive today.